- Home
- CXW vs QURE Comparison
CXW vs QURE Comparison
Compare CXW & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CXW | QURE |
|---|---|---|
| Founded | 1983 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 1997 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CXW | QURE |
|---|---|---|
| Price | $18.60 | $24.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 13 |
| Target Price | $34.00 | ★ $56.25 |
| AVG Volume (30 Days) | 917.2K | ★ 2.1M |
| Earning Date | 02-11-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 49.55 | N/A |
| EPS | ★ 1.00 | N/A |
| Revenue | ★ $2,086,522,000.00 | $15,751,000.00 |
| Revenue This Year | $12.51 | N/A |
| Revenue Next Year | $15.41 | $142.93 |
| P/E Ratio | $18.54 | ★ N/A |
| Revenue Growth | ★ 5.72 | N/A |
| 52 Week Low | $15.95 | $7.76 |
| 52 Week High | $23.54 | $71.50 |
Technical Indicators
Market Signals| Indicator | CXW | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 42.12 | 50.48 |
| Support Level | $18.27 | $22.32 |
| Resistance Level | $18.81 | $28.48 |
| Average True Range (ATR) | 0.57 | 1.83 |
| MACD | -0.14 | 0.42 |
| Stochastic Oscillator | 16.93 | 41.37 |
Price Performance
Historical ComparisonAbout CXW CoreCivic Inc.
CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.